BRCA1 and pancreatic neoplasm: Before pondering the potential for GC surveillance in BRCA1/2 PV carriers, it is relevant to first review the risk management recommendations for other malignancies associated with BRCA1/2 PVs, including breast, ovarian, prostate, and pancreatic cancer [71,72].